• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    USANA Chairman & CEO Kevin Guest Urges Leaders to Use Reading as a Competitive Advantage in National Reading Month

    3/2/26 7:27:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $USNA alert in real time by email

    SALT LAKE CITY, March 2, 2026 /CNW/ -- As businesses navigate accelerating change and increased market pressure, USANA Health Sciences (NYSE:USNA) Chairman & CEO Kevin Guest is spotlighting a powerful leadership tool during National Reading Month: disciplined, intentional reading.

    All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, by USANA CEO and chairman Kevin Guest (PRNewsfoto/USANA)

    National Reading Month, observed in March to promote literacy and lifelong learning, often emphasizes youth engagement. Guest believes its value extends far beyond the classroom and into the executive suite.

    "Reading stretches your thinking. It challenges assumptions, builds clarity, and sharpens your ability to communicate. Those are leadership skills," said Guest, bestselling author of "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony."

    While some professionals may view the heightened focus on reading as routine, Guest argues the increased emphasis this month delivers measurable returns that compound over time. He calls reading "essential training for the executive mind," strengthening mental discipline, improving analytical ability, expanding imagination, and boosting memory.

    One clear value of reading, Guest highlights, is that studying and internalizing principles strengthens character and changes destiny.

    In "All the Right Reasons," Guest reflects on Benjamin Franklin's commitment to tracking and living his core values. "By writing, prioritizing, tracking, and clarifying his core values, Franklin understood them better and developed a path for integrating them into his life," Guest wrote.

    Guest summarizes the lesson this way: "I've learned from the Ben Franklin Principle that when you commit to living according to your core values, you change your destiny."

    For Guest, that is the deeper return on reading. Intentional learning, reflection, and application of principles, often gained through reading and study, elevate character, sharpen decision-making, and ultimately shape long-term success.

    Guest has embedded this philosophy into USANA's leadership culture by highlighting the influence of "Made to Stick" by Chip Heath and Dan Heath.

    He said that one book that has influenced him greatly is "Made to Stick."

    "The principle is 'what are we doing here at USANA that makes USANA sticky?'" he said. "What makes people want to stay involved and stay connected? Those ideas, how do they blossom and how do they grow? Why do some survive and some don't?"

    Guest immediately translated insight into action. "I've asked our entire management team to read "Made to Stick" and decide which principles can be applied to their own areas throughout the company."

    For Guest, reading is not passive consumption. It is strategic execution. The lessons from "Made to Stick" inform how USANA evaluates messaging, strengthens culture, and builds long-term loyalty.

    Guest outlines five ways reading functions as a competitive advantage for successful professionals:

    1. Strategic foresight: Exposure to diverse ideas helps leaders identify patterns early and anticipate market shifts.
    2. Sharper decision-making: Engaging with complex arguments improves clarity under pressure.
    3. Cognitive resilience: Reading increases focus and strengthens composure in high-stakes moments.
    4. Stronger communication: Consistent readers articulate vision with precision and authority.
    5. Innovation through cross-pollination: Reading outside one's field introduces frameworks that spark new solutions.

    "Reading is one of the simplest habits you can develop," Guest said. "But over time, it compounds. It builds perspective. It builds insight. Simply put, readers are leaders."

    By elevating reading from hobby to discipline, Guest believes leaders strengthen their thinking, fortify their character, and position their organizations for sustained growth.

    All proceeds from sales of "All the Right Reasons" benefit  USANA Foundation. Each book purchase provides 40 meals to feed hungry children, a cause close to Guest's heart and another testament to the power of purposeful leadership. The non-profit organization has provided over 112 million meals to date.    

    For more insight, visit www.kevinguest.com.    

    About Kevin Guest  

    Kevin Guest is Chairman & CEO of USANA Health Sciences, a billion-dollar global nutritional company based in Salt Lake City. He is also a musician, author, and humanitarian. His book, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, shares lessons on leadership, integrity, and purpose drawn from his life and career.   

    ABOUT USANA HEALTH SCIENCES   

    USANA Health Sciences (NYSE:USNA), a global leader in health and wellness products, has long recognized the importance of social wellness in building a successful business. From its 1992 founding, USANA has focused on clear and concise communication to build trust with its customers and brand partners in 25 countries. For more information about USANA Health Sciences and its dedication to promoting health, wellness, and entrepreneurial success, visit USANA.com.     

    MEDIA CONTACT    

    Tim Brown, Candid Communications     

    [email protected]     

    USANA Logo (PRNewsfoto/USANA)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/usana-chairman--ceo-kevin-guest-urges-leaders-to-use-reading-as-a-competitive-advantage-in-national-reading-month-302700672.html

    SOURCE USANA

    Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2026/02/c9312.html

    Get the next $USNA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $USNA

    DatePrice TargetRatingAnalyst
    6/23/2023Buy
    Sidoti
    7/7/2022$78.00 → $53.00Hold → Underperform
    Jefferies
    4/14/2022$86.00Neutral
    DA Davidson
    More analyst ratings

    $USNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

    Issued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc

    3/5/26 9:00:00 AM ET
    $HLF
    $NHTC
    $NMTC
    Other Pharmaceuticals
    Health Care
    Consumer Specialties
    Consumer Discretionary

    190 USANA-Sponsored Athletes Earn a Record 28 Medals at 2026 Winter Olympic Games

    USANA athletes from eight national teams and 12 winter sports participated in the games SALT LAKE CITY, March 3, 2026 /PRNewswire/ -- USANA Health Sciences, Inc. (NYSE:USNA) congratulates the 190 USANA-sponsored athletes* who competed at the 2026 Winter Olympic Games, earning a total of 28 medals across 12 winter sports while representing eight national teams from four countries. US Ski & Snowboard led USANA-partnered organizations with 17 medals. USANA ambassador Alex Ferreira captured his first Olympic Gold medal in men's freeski halfpipe with a decisive final run.USANA athlet

    3/3/26 7:25:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Health Sciences to Participate in Upcoming Investor Conferences

    USANA Health Sciences, Inc. (NYSE:USNA) today announced that the Company will participate in the following upcoming conferences: Sidoti Small-Cap Virtual Conference Dates: March 18-19, 2026 Format: Fireside chat and one-on-one meetings 38th Annual ROTH Conference Date: March 23, 2026 Location: Dana Point, CA Format: One-on-one meetings A live webcast of the fireside chat at the Sidoti Small-Cap Virtual Conference will be available in the ‘News/Events' section of the Company's website at ir.usana.com. The webcast will be archived and available on the website shortly after the event. About USANA USANA develops and manufactures high-quality nutritional supplements, functional foods

    3/2/26 4:30:00 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $USNA
    SEC Filings

    View All

    $USNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CHIEF INFORMATION OFFICER Benedict Peter sold $88,259 worth of shares (4,553 units at $19.38), closing all direct ownership in the company (SEC Form 4)

    4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer)

    3/3/26 6:08:39 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    CHIEF OPERATING OFFICER Noot Walter covered exercise/tax liability with 3,144 shares and converted options into 7,422 shares, increasing direct ownership by 86% to 9,256 units (SEC Form 4)

    4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer)

    3/3/26 12:18:37 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    CHIEF COMMERCIAL OFFICER Neidig Brent converted options into 6,747 shares and covered exercise/tax liability with 2,993 shares, increasing direct ownership by 100% to 7,513 units (SEC Form 4)

    4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer)

    3/3/26 12:05:24 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 144 filed by USANA Health Sciences Inc.

    144 - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    3/3/26 4:38:42 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: USANA Health Sciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - USANA HEALTH SCIENCES INC (0000896264) (Filer)

    2/11/26 4:51:10 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by USANA Health Sciences Inc.

    SCHEDULE 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    1/21/26 1:21:12 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Sidoti initiated coverage on USANA

    Sidoti initiated coverage of USANA with a rating of Buy

    6/23/23 9:12:38 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA downgraded by Jefferies with a new price target

    Jefferies downgraded USANA from Hold to Underperform and set a new price target of $53.00 from $78.00 previously

    7/7/22 9:35:48 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    DA Davidson initiated coverage on USANA with a new price target

    DA Davidson initiated coverage of USANA with a rating of Neutral and set a new price target of $86.00

    4/14/22 7:45:27 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Leadership Updates

    Live Leadership Updates

    View All

    Kevin Guest Returns to USANA Health Sciences as CEO

    USANA Health Sciences, Inc. (NYSE:USNA) announced today a leadership transition as part of the Company's ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA's CEO and will continue serving as Chairman. Mr. Guest succeeds Jim Brown, who has stepped down from his position of CEO and President. "We thank Jim for his contributions and his leadership over the past 19 years and in his role as CEO over th

    1/8/26 9:00:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials

    USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony

    SALT LAKE CITY, April 1, 2025 /PRNewswire/ -- USANA Health Sciences (NYSE:USNA) Executive Chairman Kevin Guest marks April's convergence of International Guitar Month and Stress Awareness Month, as a perfect pairing that celebrates the healing power of music for mental well-being. While music has long been heralded as a universal remedy, the guitar offers far more than just melodies. Studies, stories and specialists alike agree: playing the guitar is a proven method to reduce stress. A passionate, performing guitarist himself, Guest invites others to join the cause. "Music has

    4/1/25 7:47:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Financials

    Live finance-specific insights

    View All

    Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments

    Issued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc

    3/5/26 9:00:00 AM ET
    $HLF
    $NHTC
    $NMTC
    Other Pharmaceuticals
    Health Care
    Consumer Specialties
    Consumer Discretionary

    USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook

    USANA Health Sciences, Inc. (NYSE:USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026. Key Financial and Operating Results   Q4 2025   Q4 2024   FY 2025   FY 2024 Net sales $226.2   $213.6   $925.3   $854.5 Net (loss) earnings* $-1.8   $4.5   $10.8   $42.0 Diluted EPS $-0.10   $0.23   $0.58   $2.19 Adjusted diluted EPS(1) $0.60   $0.64   $1.93   $2.59 Adjusted EBITDA(2) $27.3

    2/17/26 4:15:00 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook

    USANA Health Sciences, Inc. (NYSE:USNA) today announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA's strategy, including the Company's initial fiscal year 2026 sales outlook. Preliminary Fiscal Year 2025 Net Sales Results The Company currently anticipates fiscal year 2025 consolidated net sales of approximately $925 million, ahead of its most recently issued guidance of approximately $920 million. Initial Fiscal Year 2026 Net Sales Outlook The Company is issuing its initial net sales outlook for fi

    1/12/26 6:15:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by USANA Health Sciences Inc. (Amendment)

    SC 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    2/13/24 10:49:58 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by USANA Health Sciences Inc. (Amendment)

    SC 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    2/13/23 11:26:45 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by USANA Health Sciences Inc. (Amendment)

    SC 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    2/11/22 3:48:24 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care